Clinical reference Biomarker Directory
Back to directory

Ghrelin

Emerging

Ghrelin drives hunger and is markedly elevated in Prader-Willi syndrome, contributing to its characteristic insatiable appetite.

Also known as Ghrelin
In plain language

Ghrelin makes you feel hungry, working opposite to leptin discussed earlier. It's especially elevated in a genetic condition called Prader-Willi syndrome, which causes constant, hard-to-control hunger, and new drugs blocking this hormone's receptor are being developed specifically for that problem.

Biomarker & context

Ghrelin is the primary "hunger hormone," produced mainly by the stomach, signaling appetite stimulation to the brain in opposition to leptin's satiety signal (discussed earlier in this biomarker set).

What it indicates

Ghrelin is studied in the context of Prader-Willi syndrome, where markedly elevated ghrelin is thought to contribute to the syndrome's characteristic insatiable appetite (hyperphagia), a defining and challenging feature of this genetic condition.

Diagnosis & clinical testing

Measured via serum immunoassay primarily in research settings; ghrelin testing is not a standard diagnostic tool in routine clinical practice outside of specialized research on appetite-regulation disorders.

Guiding treatment

Ghrelin receptor antagonists are in development specifically for Prader-Willi-related hyperphagia, representing a targeted therapeutic approach for a notoriously difficult-to-manage symptom, though not yet a routine, widely approved treatment.

Clinical significance

Ghrelin receptor antagonists are an emerging, targeted therapeutic approach specifically for Prader-Willi-related hyperphagia.

References
  1. General endocrinology reference literature on ghrelin in Prader-Willi syndrome hyperphagia and emerging receptor antagonist therapy.